Investor Tom Hulick highlights Broadcom's AI-focused, power-efficient ASICs and Eli Lilly's GLP-1 drug pipeline, while StockStory cautions against uncritical acceptance of Wall Street price targets.
Aroldis Chapman, after a dominant 2025 season with the Boston Red Sox, firmly rejects a return to the New York Yankees, citing disrespect from the team's front office.
Roku beats Q3 estimates, raises guidance, and sees growth in its streaming platform despite device revenue decline.
Investor Tom Hulick highlights Broadcom's AI-focused, power-efficient ASICs and Eli Lilly's GLP-1 drug pipeline, while StockStory cautions against uncritical acceptance of Wall Street price targets.
Aroldis Chapman, after a dominant 2025 season with the Boston Red Sox, firmly rejects a return to the New York Yankees, citing disrespect from the team's front office.
Roku beats Q3 estimates, raises guidance, and sees growth in its streaming platform despite device revenue decline.